Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
374M
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
30.9M
-
Shares change
-
+137K
-
Total reported value, excl. options
-
$250M
-
Value change
-
-$43.6M
-
Put/Call ratio
-
0.61
-
Number of buys
-
55
-
Number of sells
-
-51
-
Price
-
$8.11
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) as of Q3 2015
132 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share as of Q3 2015.
STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.9M shares
of 374M outstanding shares and own 8.25% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (4.27M shares), FRANKLIN RESOURCES INC (2.84M shares), ORBIMED ADVISORS LLC (2.45M shares), WASATCH ADVISORS INC (2.44M shares), JPMORGAN CHASE & CO (1.99M shares), SCOPIA CAPITAL MANAGEMENT LP (1.31M shares), JENNISON ASSOCIATES LLC (1.09M shares), VANGUARD GROUP INC (998K shares), EverPoint Asset Management, LLC (900K shares), and BlackRock Fund Advisors (840K shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.